Jessica Robin Smith, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Nodule | 13 | 2022 | 764 | 1.640 |
Why?
|
| Graves Disease | 3 | 2020 | 238 | 1.340 |
Why?
|
| Hamartoma Syndrome, Multiple | 2 | 2021 | 114 | 1.020 |
Why?
|
| Thyroid Neoplasms | 11 | 2022 | 2331 | 0.860 |
Why?
|
| Antithyroid Agents | 2 | 2015 | 72 | 0.790 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2022 | 219 | 0.700 |
Why?
|
| Thyroidectomy | 5 | 2021 | 908 | 0.670 |
Why?
|
| Thyroid Gland | 7 | 2021 | 1170 | 0.610 |
Why?
|
| Thyroid Diseases | 1 | 2021 | 386 | 0.580 |
Why?
|
| Adenocarcinoma, Follicular | 3 | 2022 | 323 | 0.560 |
Why?
|
| Iodine | 1 | 2018 | 285 | 0.520 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2018 | 247 | 0.520 |
Why?
|
| Hyperthyroidism | 2 | 2015 | 294 | 0.450 |
Why?
|
| Hypothyroidism | 1 | 2018 | 668 | 0.440 |
Why?
|
| Infant, Premature, Diseases | 1 | 2018 | 710 | 0.410 |
Why?
|
| Thyrotropin | 1 | 2015 | 834 | 0.390 |
Why?
|
| Iodine Radioisotopes | 1 | 2015 | 1030 | 0.380 |
Why?
|
| Receptors, Thyrotropin | 1 | 2007 | 45 | 0.300 |
Why?
|
| Ultrasonography | 5 | 2021 | 5971 | 0.280 |
Why?
|
| Contrast Media | 1 | 2018 | 5311 | 0.250 |
Why?
|
| Adenoma | 2 | 2011 | 2159 | 0.180 |
Why?
|
| Injections, Intralymphatic | 1 | 2018 | 15 | 0.160 |
Why?
|
| Child | 17 | 2022 | 80134 | 0.160 |
Why?
|
| Autoantibodies | 1 | 2007 | 2117 | 0.160 |
Why?
|
| Cytodiagnosis | 2 | 2022 | 447 | 0.150 |
Why?
|
| Thyroid Function Tests | 1 | 2018 | 288 | 0.150 |
Why?
|
| Thyroxine | 1 | 2020 | 666 | 0.140 |
Why?
|
| Sentinel Surveillance | 1 | 2018 | 291 | 0.130 |
Why?
|
| Adolescent | 14 | 2022 | 88271 | 0.130 |
Why?
|
| Radiology Information Systems | 1 | 2019 | 529 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2021 | 1111 | 0.120 |
Why?
|
| Carcinoma, Papillary | 2 | 2018 | 785 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 974 | 0.120 |
Why?
|
| Biopsy, Fine-Needle | 4 | 2022 | 1118 | 0.120 |
Why?
|
| Male | 17 | 2022 | 360675 | 0.100 |
Why?
|
| Infant | 4 | 2020 | 36164 | 0.090 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 1496 | 0.080 |
Why?
|
| Female | 16 | 2022 | 392458 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2018 | 2106 | 0.080 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 2007 | 34 | 0.070 |
Why?
|
| Retrospective Studies | 9 | 2022 | 80673 | 0.070 |
Why?
|
| Humans | 20 | 2022 | 761098 | 0.070 |
Why?
|
| Prevalence | 2 | 2021 | 15717 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 26068 | 0.060 |
Why?
|
| Ribosomal Protein S6 | 1 | 2004 | 71 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2004 | 103 | 0.060 |
Why?
|
| Disease Progression | 1 | 2021 | 13506 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2020 | 7844 | 0.060 |
Why?
|
| Child, Preschool | 8 | 2019 | 42217 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2021 | 41486 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2019 | 26187 | 0.050 |
Why?
|
| Hospitals, Pediatric | 1 | 2011 | 1860 | 0.050 |
Why?
|
| Decision Making | 1 | 2015 | 3925 | 0.050 |
Why?
|
| Young Adult | 3 | 2022 | 59199 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15308 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2019 | 24013 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 2018 | 573 | 0.040 |
Why?
|
| Pregnancy | 1 | 2018 | 29872 | 0.030 |
Why?
|
| United States | 2 | 2021 | 72337 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2021 | 1784 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2004 | 3155 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 12975 | 0.030 |
Why?
|
| Age of Onset | 1 | 2021 | 3307 | 0.030 |
Why?
|
| Self-Examination | 1 | 2013 | 71 | 0.030 |
Why?
|
| Risk Factors | 1 | 2021 | 74219 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 2913 | 0.030 |
Why?
|
| Adult | 4 | 2022 | 221083 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1892 | 0.030 |
Why?
|
| Observer Variation | 1 | 2018 | 2611 | 0.020 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 1 | 2011 | 40 | 0.020 |
Why?
|
| Goiter | 1 | 2011 | 87 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3461 | 0.020 |
Why?
|
| Hypocalcemia | 1 | 2011 | 200 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2013 | 698 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1187 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 64670 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2013 | 2278 | 0.020 |
Why?
|
| Physical Examination | 1 | 2013 | 1255 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2019 | 3923 | 0.020 |
Why?
|
| Logistic Models | 1 | 2021 | 13254 | 0.020 |
Why?
|
| Prognosis | 2 | 2018 | 29672 | 0.020 |
Why?
|
| Radiology | 1 | 2019 | 2114 | 0.020 |
Why?
|
| Pediatrics | 1 | 2019 | 3589 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2022 | 12951 | 0.010 |
Why?
|
| Chromones | 1 | 2004 | 148 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 4908 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14676 | 0.010 |
Why?
|
| Radiography | 1 | 2013 | 6975 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18385 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2011 | 2242 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 20120 | 0.010 |
Why?
|
| Biopsy | 1 | 2013 | 6781 | 0.010 |
Why?
|
| Morpholines | 1 | 2004 | 581 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12937 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2004 | 896 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 3577 | 0.010 |
Why?
|
| Boston | 1 | 2011 | 9324 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 2091 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 6312 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3700 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 8303 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 21357 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2004 | 2527 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 12743 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2011 | 15634 | 0.000 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 16947 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 220835 | 0.000 |
Why?
|